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Long QT syndrome develops for a number of reasons. The number of non-antiarrhythmic drugs reported to induce QT interval
prolongation with or without torsade de pointes continues to increase. Clarithromycin is a macrolide antibiotic being increasingly
used for the treatment of atypical pneumonia. In this paper, we describe a patient who developed long QT prolongation syndrome
after receiving clarithromycin for the treatment of atypical pneumonia.
1.Introduction
Long QT syndrome (LQTS) is a repolarization disorder with
idiopathic, iatrogenic, and congenital etiologies that may
cause recurrent syncope attacks, life-threatening tachyar-
rhythmia, and sudden cardiac death [1, 2]. While hereditary
form of LQTS is associated with mutations of the genes that
are responsible for formation of ion channels, iatrogenic
form is more often related to drugs and electrolyte imbal-
ances. There are numerous drugs other than antiarrhythmic
ones that may cause LQTS with or without torsade de
pointes. Clarithromycin is a macrolide group antibiotic with
extended spectrum of action. Although LQTS due to ery-
thromycine has been reported frequently in the literature,
LQTS caused by clarithromycin has been rarely reported
[3, 4]. It is being used frequently for various indications in
pediatric patients. Here we presented a case of LQTS de-
veloped during clarithromycine treatment which was pre-
scribed for treating atypical pneumonia.
2.Case
A 6-years-old male child who has been started on clar-
ithromycine treatment with a diagnosis of atypical pneu-
monia 6 days ago was directed to our pediatric cardiology
clinics as cardiac murmur was noticed during his physical
examination. During taking his history we learned that he
had a syncope attack of short duration 12 hours prior to
admission to our clinic. He had no history of familial unex-
plained sudden death at younger ages or syncope attacks. In
physicalexamination,hisgeneralconditionwasgood,hewas
conscious, his cardiac rate and blood pressure were 94/min
and 100/70mmHg, respectively. There was a 2/6 systolic
murmur located in mesocardiac area. Physical examina-
tion of other systems was normal. Laboratory results includ-
ing CBC and biochemistry were normal. His ECG revealed
sin¨ us rhythm, cardiac rate of 88/min, a normal axis, QRS
duration of 60msec, QT interval of 480msec, and cQT
interval of 600msec which were long for his age, and no
T-wave abnormality or dysrhythmia (Figure 1). Echocar-
diographic evaluation was normal. In his 24-hour Holter
ECG monitorization, there were no rythm abnormalities
other than long QT interval. As he had no family history,
electrocardiographic evaluation of parents did not reveal
long QT interval and audiometric evaluation of patient
was normal, we excluded congenital LQTS. We thought
clarithromycine that he has been using may be the etiologic
factor and he stopped it. One week later his QT interval
returned to normal (420msec). Diagnosis became deﬁnite
during the one year of follow-up period in which he had no
syncope attacks and his ECGs remained normal.2 Case Reports in Medicine
Figure 1: ECG of the patient (cQT 600msec).





450 msec (in males) 1 points
Torsade de pointes 2 points
T-wave alternans 1 points
Notched T wave in 3 derivation 1 points
Low heart rate for age 0.5 points
Clinical history
Syncope
With stress 2 points
Without stress 1 points
Congenital deafness 0.5 points
Family history
Siblings with LQTS 1 points
History of sudden death before 30 years of age 0.5 points
3. Discussion
Long QT syndrome (LQTS) is a cardiac repolarization dis-
order with idiopathic, iatrogenic, and congenital etiologies
that may cause recurrent syncope attacks, life-threatening
tachyarrhythmia, and sudden cardiac death [1, 2]. Char-
acteristic ECG ﬁndings are long cQT interval for age, T-
wave abnormalities, and torsade de pointes-type ventricular
tachyarrhythmias induced by exercise [3, 4]. Iatrogenic form
is more often related to drugs and electrolyte imbalances.
Although elongation of QT interval has been reported with
antiarrhythmic drugs like quinidine, sotalol, amiodarone
and procainamide, drugs other than antiarrhythmic ones
including antihistaminics, cholinergic antagonists, antifun-
gal drugs, antipsychotics, and various antibiotics (ery-
thromycine, clarythromycine, cotrimoxazole) may cause tor-
sadedepointesbyelongatingQTinterval.Torsadedepointes
cases due to drugs are thought to be associated with blockage
of potassium channels [5]. Two cardinal ﬁndings of LQTS
are syncope and abnormalities in ECG. Underlying cause of
syncope attacks is cardiac arrythmias. Although we did not
detect any dysrhythmias in ECG and 24-hour holter evalua-
tion of our patient, we thought dysrhythmia as the probable
underlying etiology for the syncope attack. Because clinical
presentation of LQTS has been quite variable, Schwartz et al.
[6]proposedsomemajorandminorcriteriawhichhavebeen
modiﬁed for children (Table 1). According to these criteria
scores of less than 1, of 2-3, and of equal to and more than 4
are designated as low probability, medium probability, and
high probability, respectively. Presentation ﬁndings of this
syndrome are syncope attacks induced by exercise and fear.
Routine ECG and evaluation of cQT may not be adequate
sometimes. Along with that there may be T-wave abnormal-
ities and notching on T wave. 24-hour Holter ECG monitor-
ization may be useful for diagnosis [7]. As clarythromycine
usage due to pneumonia and Helicobacter pylori eradication
regimes has been increased, more cases of LQTS due to this
antibioticarebeingreported.IndividualswithborderlineQT
interval value for their age and history of cardiac disease,
antibiotics alternativetoclarythromycinethatdoes not cause
LQTS should be chosen. But again normal QT intervals in
an individual do not exclude the possibility for development
of LQTS [8]. Clarythromycine is a frequently used drug in
pediatric population for various indications. For that one
must be cautious for its side eﬀect. With this case we wanted
to emphasize that when drugs causing elongation of QT
interval are required to be used, prior electrocardiographic
evaluation of the patients should be performed, and in
individuals with long QT intervals these drugs should not
be preferred if possible or they should be used with extreme
caution with close ECG followup. In addition this case is
remarkableasitshowsthatclarythromycineusagemayresult
in serious life threatening side eﬀects related to elongated
cQT interval even in individuals with normal QT intervals.
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